Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Washington [US], May 2 (ANI): A multi-institutional study, drove by the Proceedings of the National Academy of Sciences journal, distinguished both the hereditary abnormalities that drive pre-cancer cells that lead to an intrusive kind of head and neck cancer and patients who are liable to r
Washington [US], April 27 (ANI): A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
Los Angeles [US], March 28 (ANI): Researchers from the UCLA School of Dentistry, during a recent study, were successful in significantly slowing down the growth and spread of tumors in mice by targeting an enzyme that plays a key role in head and neck cancer cells. This also enhanced the eff
Los Angeles [US], March 24 (ANI): Researchers from the UCLA School of Dentistry were able to significantly slow the growth and spread of tumors in mice by targeting an enzyme that plays a key role in head and neck cancer cells. They were also able to enhance the effectiveness of immunotherap
Brisbane [Australia], August 1 (ANI): Discovery of new cellular immunotherapy that targets a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates, said Queensland scientists.
Brisbane [Australia], July 28 (ANI): Queensland scientists say the discovery of new cellular immunotherapy that targets a deadly type of head and neck cancer, caused by human papillomavirus (HPV), could lead to better survival rates.
Bengaluru (Karnataka) [India], July 27 (ANI/BusinessWire India): CANCON 2019, the 3rd edition of scientific deliberations on head and neck cancer management, powered by Cytecare Cancer Hospitals in Bengaluru, commenced on a pleasantly unusual note. Nalini Satyanarayan, 70, played the flute t
Washington DC, [USA] Aug 06 (ANI): According to a recent study, childhood trauma history should be considered during treatment for Head and Neck Cancer (HNC) as people who experience childhood trauma are more likely to have advanced cancer.